Skip to content

Effect of High Intensity Laser on Hemiplegic Shoulder Dysfunction

Effect of High Intensity Laser on Hemiplegic Shoulder Dysfunction Double Blinded, Placebo-controlled Trial

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05595720
Enrollment
44
Registered
2022-10-27
Start date
2022-10-20
Completion date
2023-01-20
Last updated
2023-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shoulder Dislocation or Subluxation, Stroke

Keywords

Stroke,, Shoulder dysfunction, High intensity laser

Brief summary

Hemiplegic shoulder pain (HSP) is a common and disabling complication following a stroke, and it may affect the quality of life. It often occurs following two to three months of stroke. Upper limb impairment is seen in 90% of patients affected by stroke. Numerous causes have been implicated in developing HSP in stroke. This includes muscle flaccidity around the shoulder joint, shoulder subluxation, shoulder-hand syndrome, increased muscle tone, impingement syndrome, frozen shoulder, brachial plexus injury, and the thalamic syndrome. Muscle paresis, abnormal muscle tone and loss of proprioception following stroke may render the shoulder complex unstable and therefore prone to misalignment. In recent years, high-intensity laser therapy (HILT) has been considered as a treatment option for shoulder pain. HILT increases microcirculation and tissue regeneration and lowers edema, inflammation, and pain with its photomechanical, thermal, electrical, and bio stimulating effects in deep tissues that cannot be reached with LILT. It has some advantages over LILT, i.e., having higher power, greater tissue penetration capacity to deep tissues, the short emission time, and long rest periods preventing heat accumulation. In recent studies, effectiveness of HILT has been shown in the treatment of subacromial impingement syndrome, rotator cuff tendinopathy, and frozen shoulder.

Interventions

DEVICEhight intenisty laser

7W(LAZR-207)/15W(LAZR-215&115)HIGH POWER LASER THERAPYUNIT WITH 2 WAVELENGTHMODES,COMBINATION(810+980 NM) AND SINGLE(1064 NM)

Sponsors

Deraya University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* DISORDER MORE THAN 6 MONTHS * UNILATERAL * FIRST TIME

Exclusion criteria

* Iinflammatory rheumatic disease, * cervical radiculopathy, * diabetes mellitus, * thyroid disease, * coronary heart disease, * cardiac pacemaker, * neurological disease, * shoulder surgery, and * shoulder injection in the last 3 months

Design outcomes

Primary

MeasureTime frameDescription
PAIN score1 MONTHMcGill pain questioner scale, scoring from zero to 78 zero is the best score seventy eight is the worst score
FUNCTION1 MONTHUCLA shoulder score from zero to 35 zero is the worst 35 is the best

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026